Performance

GENB +12.09%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
GENB	+8.58%	+12.09%*	+12.09%*	—	-40.68%*	0.59*	0.00%*

Summary

GENB at a glance

GENB returned +12.09% since Feb 27, 2026. Its worst drop since then was -40.68%, smaller than 36% of stocks on Redstone, and its Sharpe ratio of 0.59 beats 55% of stocks on Redstone. It hasn't paid a dividend since it listed.

Ranking

How GENB ranks

Dividend Yield Rank *

Current Drawdown

-30.42%

Rolling Volatility

108.06%

Actions

Metrics

Risk Indicators*

Alpha30.58%

Beta1.81x

Sharpe0.59

Sortino0.83

Omega1.11

Calmar0.30

Martin2.67

Profile

About GENB

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $1.8B
Listed: Feb 2026
Headquarters: Somerville, MA
Website: generatebiomedicines.com

Comparisons

GENB: Generate Biomedicines, Inc.

GENB at a glance

How GENB ranks

Current Drawdown

Rolling Volatility

About GENB

Related comparisons